Exact Sciences
EXAS
#1384
Rank
โ‚ฌ11.80 B
Marketcap
63,92ย โ‚ฌ
Share price
2.34%
Change (1 day)
-9.27%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total assets

Total assets on the balance sheet as of June 2024 : โ‚ฌ6.02 B

According to Exact Sciences's latest financial reports the company's total assets are โ‚ฌ6.02 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exact Sciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2023-12-31โ‚ฌ5.85 B0.84%
2022-12-31โ‚ฌ5.80 B-1.21%
2021-12-31โ‚ฌ5.87 B45.84%
2020-12-31โ‚ฌ4.02 B29.04%
2019-12-31โ‚ฌ3.12 B134.69%
2018-12-31โ‚ฌ1.33 B166.69%
2017-12-31โ‚ฌ0.49 B39.17%
2016-12-31โ‚ฌ0.35 B7.5%
2015-12-31โ‚ฌ0.33 B29.76%
2014-12-31โ‚ฌ0.25 B142.13%
2013-12-31โ‚ฌ0.10 B25.12%
2012-12-31โ‚ฌ84.82 M13.63%
2011-12-31โ‚ฌ74.65 M2.63%
2010-12-31โ‚ฌ72.74 M304.12%
2009-12-31โ‚ฌ18 M330.58%
2008-12-31โ‚ฌ4.18 M-57.77%
2007-12-31โ‚ฌ9.89 M-45.27%
2006-12-31โ‚ฌ18.08 M-43.38%
2005-12-31โ‚ฌ31.94 M-13.92%
2004-12-31โ‚ฌ37.11 M33.67%
2003-12-31โ‚ฌ27.76 M-42.05%
2002-12-31โ‚ฌ47.91 M-32.94%
2001-12-31โ‚ฌ71.44 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚ฌ0.97 B-83.74%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.11 B-81.50%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ19.94 M-99.67%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ125.51 B 1,984.35%๐Ÿ‡ซ๐Ÿ‡ท France